NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Corryn Biotechnologies

Corryn Biotechnologies

Private
SwanseaHealthcare & Life Scienceshttps://dermaweave.co.uk/

Last Round

Seed

Apr 1, 2026

Total Funding Raised

$1.98M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Corryn Biotechnologies is a medical technology company developing a handheld device to fabricate and deposit biomimetic fibrous wound dressings directly upon wound sites at the point of care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

electrospinningwound dressingpoint-of-caremedical deviceresorbable dressingbiomaterialscosmetic aftercarerazor-and-bladewound caremedtechtissue engineeringdermatology technologyconsumable cartridgescontactless dressing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Corryn Biotechnologies Comps

Public and private peers based on sector, stage, and business model.

Corryn Biotechnologies comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Corryn Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 1, 2026
SeedSep 17, 2024
GrantMay 14, 2024
GrantJul 3, 2023
GrantMay 1, 2023
Grant
Jul 7, 2021

Key People

Founding team and executive leadership

Fabio Zomer Volpato

Co-Founder And Chief Operations Officer

Founding Team

Luke Burke

Chief Executive Officer

Executive Team

Corryn Biotechnologies Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 8, 2026

    Added 1 new job posting, representing 25% of headcount.

  • Apr 2, 2026

    $635K raised in early funding.

Corryn Biotechnologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Corryn Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Corryn Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersSwansea
Employee Range4
Year Founded2021
Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.